HK1096379A1 - Sulfonamide derivatives for the treatment of diseases - Google Patents

Sulfonamide derivatives for the treatment of diseases

Info

Publication number
HK1096379A1
HK1096379A1 HK07103436.9A HK07103436A HK1096379A1 HK 1096379 A1 HK1096379 A1 HK 1096379A1 HK 07103436 A HK07103436 A HK 07103436A HK 1096379 A1 HK1096379 A1 HK 1096379A1
Authority
HK
Hong Kong
Prior art keywords
diseases
treatment
sulfonamide derivatives
sulfonamide
derivatives
Prior art date
Application number
HK07103436.9A
Inventor
Alan Daniel Brown
Mark Edward Bunnage
Paul Alan Glossop
Kim James
Charlotte Alice Louise Lane
Russell Andrew Lewthwaite
Ian Brian Moses
David Anthony Price
Nicholas Murray Thomson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34890770&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1096379(A1) "Global patent litigation datasetā€ by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0406387A external-priority patent/GB0406387D0/en
Priority claimed from PCT/IB2005/000086 external-priority patent/WO2005080313A2/en
Application filed by Pfizer filed Critical Pfizer
Publication of HK1096379A1 publication Critical patent/HK1096379A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methanthelineĀ 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • A61K31/522Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/08Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
HK07103436.9A 2004-01-22 2007-03-30 Sulfonamide derivatives for the treatment of diseases HK1096379A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP04290169 2004-01-22
GB0406387A GB0406387D0 (en) 2004-03-22 2004-03-22 Sulfonamide derivatives for the treatment of diseases
US60026004P 2004-08-09 2004-08-09
PCT/IB2005/000086 WO2005080313A2 (en) 2004-01-22 2005-01-12 Sulfonamide derivatives for the treatment of diseases

Publications (1)

Publication Number Publication Date
HK1096379A1 true HK1096379A1 (en) 2007-06-01

Family

ID=34890770

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07103436.9A HK1096379A1 (en) 2004-01-22 2007-03-30 Sulfonamide derivatives for the treatment of diseases

Country Status (7)

Country Link
CR (1) CR9838A (en)
CY (1) CY1107107T1 (en)
EC (1) ECSP066700A (en)
HK (1) HK1096379A1 (en)
HR (1) HRP20070542T3 (en)
IL (1) IL176564A (en)
MA (1) MA28302A1 (en)

Also Published As

Publication number Publication date
CY1107107T1 (en) 2012-10-24
ECSP066700A (en) 2006-10-31
IL176564A0 (en) 2006-10-31
HRP20070542T3 (en) 2008-02-29
CR9838A (en) 2008-04-21
MA28302A1 (en) 2006-11-01
IL176564A (en) 2011-11-30

Similar Documents

Publication Publication Date Title
IL176629A0 (en) Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en) Sulfonamide derivatives for the treatment of diseases
IL227841A0 (en) Dihydropteridinones for the treatment of cancer diseases
HUS1500034I1 (en) Indolidone derivatives for the treatment or prevention of fibrotic diseases
HK1207821A1 (en) Improved modalities for the treatment of degenerative diseases of the retina
IL184934A0 (en) 4-oxoquinazoline-3-yl-benzamide derivatives for the treatment of cytokine diseases
ZA200701584B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
PT2056804E (en) Use of 2,5-dihydroxybenzene derivatives for the treatment of ocular diseases
GB0523961D0 (en) The treatment of ophthalmic diseases
GB0400802D0 (en) Compounds for the treatment of disease
GB0523964D0 (en) The treatment of ophthalmic diseases
ZA200606780B (en) Compounds for the treatment of diseases
HK1096379A1 (en) Sulfonamide derivatives for the treatment of diseases
GB0406388D0 (en) Sulfonamide derivatives for the treatment of diseases
GB0406387D0 (en) Sulfonamide derivatives for the treatment of diseases
GB0408297D0 (en) Indole derivatives for the treatment of diseases
GB0425054D0 (en) Formamide derivatives for the treatment of diseases
IL177531A0 (en) Compounds for the treatment of diseases
GB0420867D0 (en) Compounds for the treatment of diseases
GB0425073D0 (en) Compounds for the treatment of diseases
AP2006003743A0 (en) Compounds useful for the treatment of diseases
GB0425064D0 (en) Compounds useful for the treatment of diseases
GB0523962D0 (en) The treatment of ophthalmic diseases
GB0523965D0 (en) The treatment of ophthalmic diseases
GB0415352D0 (en) Compounds for the treatment of disease

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140112